comprehensive -WSS

comprehensive

author：focus 2025-10-01 11:00:54 - browse：25159

U.S. Sen. Bernie Sanders sets his hands on two chairs as two people set up a board displaying a "price of drugs" chart behind him — politics coverage from STAT — Sen. Bernie Sanders has used his leadership of a Senate committee to pressure drugmakers to lower their prices. Kevin Dietsch/Getty Images

WASHINGTON — Bernie Sanders is figuring out just how far bullying drugmakers can take him.

For more than a year, Sanders has used his perch atop the Senate health committee to haul the CEOs of pharmaceutical companies that make insulin, vaccines, and more before the panel with progressively more ambitious demands related to their pricing. After a few victories he’s claimed — experts say some credit is deserved, but the full story is a bit more complicated — he’s now progressed to demanding that Novo Nordisk cut its price for its novel, wildly popular diabetes and weight-loss drugs.

Sanders (I-Vt.) is testing the limits of the powers of a Senate chairman with little hope of advancing his policy agenda legislatively. He’s threatened subpoenas, held a prominent nominee hostage, and initiated investigations to get his way. It’s a sharp departure from the modest, bipartisan ambitions that more disciplined, discreet leaders of the committee have taken in years past, and sets the bar for how much can be accomplished using the full extent of the bully pulpit.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： AstraZeneca to buy developer of next

WSS

1 dead, 9 hurt in July 4th fireworks explosion

Palestinian attacker wounds 8 in Tel Aviv as Israel presses on with West Bank operation

Baby aspirin cuts fat buildup in liver disease patients, in small study

Kremlin open to talks over potential prisoner swap involving detained US reporter Evan Gershkovich

Churchill Downs extends trainer Bob Baffert's ban through 2024

CVS Caremark has created a new ploy: the drug ‘rebate credit’

Wikipedia

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

hotspot

Drug repurposing or repositioning? The language matters

App could help diagnose ear infections more accurately — and at home

New air purifier tech could be key to improving indoor air quality

Asbestos, a deadly carcinogen, banned by EPA

Continuity nursing helped my family in our darkest PICU moments

Leading voice in opioid treatment defends methadone clinic system

Psychedelics group wrestles with new pharma identity

Kremlin open to talks over potential prisoner swap involving detained US reporter Evan Gershkovich

Trump demands the U.S. pay no more for drugs than other countries … again

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

hotspot

US ambassador visits Wall Street Journal reporter detained in Russia on charges of espionage

Colonoscopy prep: Liquid

Stop the failed accountable care organization experiment

Colonoscopy prep: Liquid

Virtual Event: March of the Biosimilars

Asbestos, a deadly carcinogen, banned by EPA

focus

Wikipedia

entertainment

Wikipedia